Martin Brecher, MD

Quetiapine vs Lithium for Bipolar

January 26, 2010

Read a study comparing the efficacy and tolerability of quetiapine and lithium monotherapy with a placebo for a major depressive episode in bipolar disorder.

Allan H. Young, Susan L. McElroy, Michael Bauer, et al

Original Research

A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)

January 26, 2010

Susan L. McElroy, Richard H. Weisler, William Chang, et al

Original Research

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study

April 7, 2009

Michael Bauer, Herman W. Pretorius, Eric L. Constant, et al

Original Research

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study

April 7, 2009

Andrew J. Cutler, Stuart A. Montgomery, David Feifel, et al

Original Research

A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone

April 7, 2009

John W. Newcomer, Robert E. Ratner, Jan W. Eriksson, et al

Original Research

Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Acute Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study

June 15, 2007

René S. Kahn, S. Charles Schulz, Veselin D. Palazov, et al

Original Research

Quetiapine and Long-Term Weight Change: A Comprehensive Data Review of Patients With Schizophrenia

April 16, 2007

Martin Brecher, Ronald W. Leong, Göran Stening, et al

Letter to the Editor

Reply to A Discussion of 2 Double-Blind Studies Comparing Risperidone and Quetiapine in Patients With Schizophrenia

February 15, 2007

Dennis E. Sweitzer, Arthur Lazarus, Martin Brecher

Original Research

A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder

January 15, 2005

Charles L. Bowden, Heinz Grunze, Jamie Mullen, et al

Letter to the Editor

Clarification of Anticholinergic Effects of Quetiapine

September 30, 2000

Jeffrey M. Goldstein, Martin Brecher

Article

Psychopharmacology of Atypical Antipsychotics and Clinical Outcomes in Elderly Patients

June 1, 1999

Vinod Kumar, Martin Brecher

Original Research

Comparison of Risperidone and Placebo for Psychosis and Behavioral Disturbances Associated With Dementia: A Randomized, Double-Blind Trial

February 28, 1999

Ira R. Katz, Dilip V. Jeste, Jacobo E. Mintzer, et al

Quetiapine vs Lithium for Bipolar

A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study

A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone

Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Acute Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study

Quetiapine and Long-Term Weight Change: A Comprehensive Data Review of Patients With Schizophrenia

Reply to A Discussion of 2 Double-Blind Studies Comparing Risperidone and Quetiapine in Patients With Schizophrenia

A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder

Clarification of Anticholinergic Effects of Quetiapine

Psychopharmacology of Atypical Antipsychotics and Clinical Outcomes in Elderly Patients

Comparison of Risperidone and Placebo for Psychosis and Behavioral Disturbances Associated With Dementia: A Randomized, Double-Blind Trial

ELSEWHERE:

FOLLOW US:

Martin Brecher, MD

Quetiapine vs Lithium for Bipolar

A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study

A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone

Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Acute Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study

Quetiapine and Long-Term Weight Change: A Comprehensive Data Review of Patients With Schizophrenia

Reply to A Discussion of 2 Double-Blind Studies Comparing Risperidone and Quetiapine in Patients With Schizophrenia

A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder

Clarification of Anticholinergic Effects of Quetiapine

Psychopharmacology of Atypical Antipsychotics and Clinical Outcomes in Elderly Patients

Comparison of Risperidone and Placebo for Psychosis and Behavioral Disturbances Associated With Dementia: A Randomized, Double-Blind Trial

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles